Q3 2025 Balchem Corp Earnings Call Transcript
Key Points
- Balchem Corp (BCPC) reported record quarterly consolidated sales of $268 million, an 11.5% increase from the prior year.
- The company achieved its 25th consecutive quarter of year-over-year growth in adjusted EBITDA.
- Strong performance was noted across all three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
- The Human Nutrition & Health segment saw a 14.3% increase in sales, driven by demand for minerals, nutrients, and food ingredients.
- Balchem Corp (BCPC) successfully managed to offset the impact of tariffs through alternate supply chain options and pricing actions.
- Consolidated operating expenses increased to $41 million from $37 million in the prior year, due to higher professional services and compensation-related costs.
- The effective tax rate slightly decreased to 22.6% from 22.9%, but tax-related challenges remain a concern.
- The company faces ongoing challenges in penetrating the market with its lesser-known nutrient products.
- The process of addressing international antidumping practices is lengthy and expensive, impacting strategic initiatives.
- Balchem Corp (BCPC) is nearing capacity limits in its encapsulates business, necessitating significant investment in new facilities.
Thank you for standing by. My name is Jeannie, and I will be your conference operator today. At this time, I would like to welcome everyone to the Balchem's third quarter 2025 earnings call.
(Operator Instructions)
I would now like to turn the call over to Martin Bengtsson, CFO. Please go ahead.
Thank you. Good morning, everyone. Thank you for joining our conference call this morning to discuss the results of Balchem Corporation for the quarter ending September 30, 2025. My name is Martin Bengtsson, Chief Financial Officer, and hosting this call with me is Ted Harris, our Chairman, President and CEO.
Following the advice of our counsel, auditors and the SEC, at this time, I would like to read our forward-looking statement. Statements made in today's call that are not historical facts are considered forward-looking statements.
We can give no assurance of the expectations reflected in forward-looking statements will prove correct, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

